Search - tctmd.com

Displaying 1 - 20 of 272

Sort: Relevancy | Date

News Conference News ACC 2026

Financial Support After Hospital Discharge Boosts HFrEF Outcomes: FUND-HF

L.A. McKeown

April 08, 2026

News Conference News ACC 2026

DIG-RHD: Digoxin Effective in Rheumatic Heart Disease

Michael O'Riordan

April 06, 2026

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2026

Caitlin E. Cox

April 01, 2026

News Conference News ACC 2026

SMART-DECISION: Stopping Beta-blockers Post-MI Safe in Stable Patients

Michael O'Riordan

March 30, 2026

News Opinion CV Team Dispatch

March 2026 Dispatch for the CV Team

L.A. McKeown

March 26, 2026

News Conference News ACC 2026

What’s Going to Be Hot at ACC 2026

Michael O'Riordan

March 20, 2026

News Conference News CRT 2026

TAVR-MET: Early Signs Point to Less Postprocedural Valve Dysfunction With Tirzepatide

L.A. McKeown

March 19, 2026

News Daily News

Oral GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis

L.A. McKeown

February 06, 2026

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2026

Caitlin E. Cox

February 02, 2026

News Daily News

Even With Optimized GDMT, HFrEF Prognosis Remains Dire

Michael O'Riordan

January 30, 2026

News Daily News

HF Care Differs Among Asian Subgroups in the US

L.A. McKeown

January 16, 2026

News Daily News

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Michael O'Riordan

December 30, 2025

News Opinion CV Team Dispatch

December 2025 Dispatch for the CV Team

L.A. McKeown

December 23, 2025

News Opinion CV Team Dispatch

November 2025 Dispatch for the CV Team

L.A. McKeown

November 24, 2025

News Daily News

PREVENT-TAHA8: Post-MI Intracoronary Stem Cells May Lower HF Risk After STEMI

L.A. McKeown

November 04, 2025

News Opinion CV Team Dispatch

October 2025 Dispatch for the CV Team

L.A. McKeown

October 25, 2025

News Daily News

Risk Factors Present in Nearly All Patients Who Develop CVD

Michael O'Riordan

October 02, 2025

News Conference News ESC 2025

ESC Guidelines Update Clarifies Pregnancy Risks and Choices in Women With CVD

L.A. McKeown

September 09, 2025

News Conference News ESC 2025

Digitoxin Cuts Risk in Well-Treated HFrEF Patients: DIGIT-HF

Michael O'Riordan

August 29, 2025

News Opinion Editor's Corner ESC 2025

What’s Going to Be Hot at ESC Congress 2025?

Michael O'Riordan

August 25, 2025

Advertisement

Financial Support After Hospital Discharge Boosts HFrEF Outcomes: FUND-HF

DIG-RHD: Digoxin Effective in Rheumatic Heart Disease

TCTMD’s Top 10 Most Popular Stories for March 2026

SMART-DECISION: Stopping Beta-blockers Post-MI Safe in Stable Patients

March 2026 Dispatch for the CV Team

What’s Going to Be Hot at ACC 2026

TAVR-MET: Early Signs Point to Less Postprocedural Valve Dysfunction With Tirzepatide

Oral GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis

TCTMD’s Top 10 Most Popular Stories for January 2026

Even With Optimized GDMT, HFrEF Prognosis Remains Dire

HF Care Differs Among Asian Subgroups in the US

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

December 2025 Dispatch for the CV Team

November 2025 Dispatch for the CV Team

PREVENT-TAHA8: Post-MI Intracoronary Stem Cells May Lower HF Risk After STEMI

October 2025 Dispatch for the CV Team

Risk Factors Present in Nearly All Patients Who Develop CVD

ESC Guidelines Update Clarifies Pregnancy Risks and Choices in Women With CVD

Digitoxin Cuts Risk in Well-Treated HFrEF Patients: DIGIT-HF

What’s Going to Be Hot at ESC Congress 2025?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content